Olympus Corporation (OTCPK:OLYMY) Q1 2025 Earnings Conference Call August 7, 2024 2:00 AM ET Company Participants Stefan Kaufmann - Executive President, CEO & Director Tatsuya Izumi - Executive Officer & CFO Gabriela Kaynor - Executive Officer, Chief Strategy Officer Conference Call Participants Stefan Kaufmann Hello, everyone. I'm Stefan Kaufmann, CEO, and welcome to today's earnings call.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Stefan Kaufmann CEO | OTC PINK Exchange | JP3201200007 ISIN |
| Japan Country | 28,838 Employees | 31 Mar 2026 Last Dividend | 27 Mar 2019 Last Split | - IPO Date |
Olympus Corporation, originally known as Olympus Optical Co., Ltd., is a global leader in the manufacturing and sale of precision machinery and instruments. The company has a rich history that dates back to its inception in 1919 and has its headquarters situated in Tokyo, Japan. Over the years, Olympus Corporation has undergone significant transformations, including a name change in October 2003, to better reflect its diversified product range and global presence. Olympus operates through four main business segments: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and Others. Each of these segments is geared towards providing innovative solutions in their respective fields, contributing to Olympus's reputation as a pioneer in medical and scientific equipment.
This segment delivers a comprehensive array of gastrointestinal and surgical endoscopy systems alongside surgical microscopes. Olympus also offers endoscope reprocessors and maintenance services, ensuring the durability and reliability of its endoscopic products. The focus here is on enhancing the efficiency of medical procedures and improving patient outcomes through state-of-the-art imaging and minimally invasive techniques.
Olympus's offering in this domain includes a variety of products for urology, gynecology, respiratory care, as well as ear, nose, and throat (ENT) treatments. The segment is particularly noted for its GI endo-therapy devices, energy devices, and surgical single-use devices, which are designed to facilitate complex therapeutic procedures with precision and care.
This segment caters to the needs of the scientific community, providing biological and industrial microscopes, industrial videoscopes, and non-destructive testing equipment. Additionally, Olympus supplies X-ray fluorescence (XRF) analyzers, instruments key in material analysis across various industries. The focus here is on delivering precision, enhancing research capabilities, and contributing to the advancement of science and industry.
Under this segment, Olympus develops and supplies biomedical materials such as synthetic bone fillers and orthopedic equipment. These products are a testament to Olympus’s commitment to extending its technological expertise beyond traditional boundaries and meeting the diverse needs of its global clientele.